Amicus Therapeutics Inc (FOLD) is a biotechnology company listed on US.
Latest reported FOLD revenue for 2024-12-31 was $528.3M. Net income was -$56.1M. Revenue was up 32.3% from 2023-12-31 to 2024-12-31. FOLD currently screens at market cap $1.80B.
Use this FOLD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FOLD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FOLD SEC filings page. Lician reads the product cache first so this HTML stays unique to Amicus Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FOLD income, balance, and cash tables.